AU2001280471A1 - Novel secreted proteins and their uses - Google Patents
Novel secreted proteins and their usesInfo
- Publication number
- AU2001280471A1 AU2001280471A1 AU2001280471A AU8047101A AU2001280471A1 AU 2001280471 A1 AU2001280471 A1 AU 2001280471A1 AU 2001280471 A AU2001280471 A AU 2001280471A AU 8047101 A AU8047101 A AU 8047101A AU 2001280471 A1 AU2001280471 A1 AU 2001280471A1
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- novel secreted
- novel
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22464200P | 2000-08-11 | 2000-08-11 | |
US60/224,642 | 2000-08-11 | ||
US24177900P | 2000-10-19 | 2000-10-19 | |
US60/241,779 | 2000-10-19 | ||
PCT/US2001/021124 WO2002014358A2 (en) | 2000-08-11 | 2001-07-30 | Novel secreted proteins and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001280471A1 true AU2001280471A1 (en) | 2002-02-25 |
Family
ID=26918895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001280471A Abandoned AU2001280471A1 (en) | 2000-08-11 | 2001-07-30 | Novel secreted proteins and their uses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1309614A2 (en) |
AU (1) | AU2001280471A1 (en) |
WO (1) | WO2002014358A2 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030149238A1 (en) * | 2000-02-14 | 2003-08-07 | Pankaj Agarwal | Novel compounds |
US7247717B2 (en) | 2000-11-14 | 2007-07-24 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
JP2007063225A (en) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | Imidazopyridine compound |
JP5302012B2 (en) | 2006-03-08 | 2013-10-02 | タケダ カリフォルニア インコーポレイテッド | Glucokinase activator |
WO2007143434A2 (en) | 2006-05-31 | 2007-12-13 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
WO2008057459A2 (en) | 2006-11-07 | 2008-05-15 | Merck & Co., Inc. | Antagonists of pcsk9 |
US8163779B2 (en) | 2006-12-20 | 2012-04-24 | Takeda San Diego, Inc. | Glucokinase activators |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
EP2142217B1 (en) | 2007-03-27 | 2014-11-05 | Merck Sharp & Dohme Corp. | Method for detecting autoprocessed, secreted pcsk9 |
JOP20080381B1 (en) | 2007-08-23 | 2023-03-28 | Amgen Inc | Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9) |
AR070315A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | ANTIBODIES 1B20 ANTAGONISTS OF PCSK9 |
AR070316A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | PCSK9 ANTAGONISTS (SUBTILISINE-KEXINA TYPE 9 PROPROTEIN) |
WO2010068526A1 (en) | 2008-12-12 | 2010-06-17 | Merck Sharp & Dohme Corp. | Pcsk9 immunoassay |
AU2010313381A1 (en) | 2009-10-30 | 2012-04-12 | Merck Sharp & Dohme Corp. | AX1 and AX189 PCSK9 antagonists and variants |
IN2012DN03824A (en) | 2009-10-30 | 2015-08-28 | Merck Sharp & Dohme | |
TR201806936T4 (en) | 2010-01-29 | 2018-06-21 | Chugai Pharmaceutical Co Ltd | Anti-dll3 antibody. |
AR087715A1 (en) | 2011-09-16 | 2014-04-09 | Lilly Co Eli | ANTI PCSK9 ANTIBODIES AND USES OF THE SAME |
EP2817338B1 (en) | 2012-02-24 | 2017-07-26 | AbbVie Stemcentrx LLC | Dll3 modulators and methods of use |
AR091462A1 (en) | 2012-06-15 | 2015-02-04 | Genentech Inc | ANTI-PCSK9 ANTIBODIES, FORMULATIONS, DOSAGE AND METHODS OF USE |
AU2014218730B2 (en) | 2013-02-22 | 2018-12-13 | Abbvie Stemcentrx Llc | Novel antibody conjugates and uses thereof |
CA2922547C (en) | 2013-08-28 | 2020-03-10 | Stemcentrx, Inc. | Site-specific antibody conjugation methods and compositions |
US9067998B1 (en) | 2014-07-15 | 2015-06-30 | Kymab Limited | Targeting PD-1 variants for treatment of cancer |
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US9051378B1 (en) | 2014-07-15 | 2015-06-09 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9045545B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision medicine by targeting PD-L1 variants for treatment of cancer |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
US9023359B1 (en) | 2014-07-15 | 2015-05-05 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9034332B1 (en) | 2014-07-15 | 2015-05-19 | Kymab Limited | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US8945560B1 (en) | 2014-07-15 | 2015-02-03 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US8883157B1 (en) | 2013-12-17 | 2014-11-11 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9045548B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US9914769B2 (en) | 2014-07-15 | 2018-03-13 | Kymab Limited | Precision medicine for cholesterol treatment |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
EP3107576A4 (en) | 2014-02-21 | 2017-09-06 | Abbvie Stemcentrx LLC | Anti-dll3 antibodies and drug conjugates for use in melanoma |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
US9150660B1 (en) | 2014-07-15 | 2015-10-06 | Kymab Limited | Precision Medicine by targeting human NAV1.8 variants for treatment of pain |
US9139648B1 (en) | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
WO2018083248A1 (en) | 2016-11-03 | 2018-05-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
KR102569848B1 (en) | 2016-12-23 | 2023-08-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Gene editing of PCSK9 |
JP7314146B2 (en) | 2017-12-28 | 2023-07-25 | 中外製薬株式会社 | Cytotoxicity-inducing therapeutic agent |
JP7085666B2 (en) | 2020-03-31 | 2022-06-16 | 中外製薬株式会社 | PLL3 target multispecific antigen-binding molecule and its use |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916751A (en) * | 1996-08-27 | 1999-06-29 | University Of South Florida | Method for the diagnosis of selected adenocarcinomas |
AU8580098A (en) * | 1997-07-31 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor, lefty-2 |
WO1999009198A1 (en) * | 1997-08-21 | 1999-02-25 | Human Genome Sciences, Inc. | Human nodal and lefty homologues |
US6027917A (en) * | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
JP2003525591A (en) * | 1999-04-29 | 2003-09-02 | ノース・ショア・ロング・アイランド・ジューイッシュ・リサーチ・コーポレイション | Methods for inducing neural tissue growth and enhancing survival |
-
2001
- 2001-07-30 EP EP01958861A patent/EP1309614A2/en not_active Withdrawn
- 2001-07-30 AU AU2001280471A patent/AU2001280471A1/en not_active Abandoned
- 2001-07-30 WO PCT/US2001/021124 patent/WO2002014358A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1309614A2 (en) | 2003-05-14 |
WO2002014358A3 (en) | 2003-03-13 |
WO2002014358A2 (en) | 2002-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280471A1 (en) | Novel secreted proteins and their uses | |
AU7602400A (en) | Secreted proteins and uses thereof | |
AU2001271683A1 (en) | Novel secreted proteins | |
AU2001237958A1 (en) | 22 human secreted proteins | |
AU2002233994A1 (en) | Secreted proteins | |
AU2001227833A1 (en) | 71 human secreted proteins | |
AU2001270045A1 (en) | Secreted proteins | |
AU2002232596A1 (en) | Secreted human proteins | |
AU6394400A (en) | Secreted proteins and uses thereof | |
AU2001255320A1 (en) | Secreted proteins | |
AU2001237957A1 (en) | 17 human secreted proteins | |
AU2001245308A1 (en) | 207 human secreted proteins | |
AU2396600A (en) | Secreted proteins and uses thereof | |
AU2002211220A1 (en) | Secreted proteins and their uses | |
AU5750200A (en) | Secreted proteins and uses thereof | |
AU2001290551A1 (en) | Secreted proteins and their uses | |
AU2002236440A1 (en) | Novel secreted proteins and their uses | |
AU2001294719A1 (en) | Secreted human proteins | |
AU3382800A (en) | Secreted proteins and uses thereof | |
WO2000069885A8 (en) | Secreted proteins and uses thereof | |
AU1190801A (en) | Secreted proteins and uses thereof | |
AU2001229366A1 (en) | Secreted proteins | |
AU2001255668A1 (en) | 29 human secreted proteins | |
AU2001229507A1 (en) | 21 human secreted proteins | |
AU2001283327A1 (en) | 8 human secreted proteins |